garenoxacin has been researched along with Pneumonia, Pneumococcal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, Y; Furuya, Y; Mitsuyama, J; Nomura, N; Nozaki, Y; Takahata, M | 1 |
| Azoulay-Dupuis, E; Bédos, JP; Cherbuliez, C; Fantin, B; Isturiz, R; Köhler, T; Mohler, J; Moine, P; Péchère, JC; Peytavin, G; Rieux, V | 1 |
| Fritsche, TR; Jones, RN; Sader, HS; Stilwell, MG | 1 |
3 other study(ies) available for garenoxacin and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infection.
Topics: Animals; Anti-Bacterial Agents; Coinfection; Disease Models, Animal; Female; Fluoroquinolones; Influenza A virus; Lung; Mice; Orthomyxoviridae Infections; Pneumonia, Pneumococcal; Respiratory Mucosa; Streptococcus pneumoniae | 2014 |
Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.
Topics: Animals; Anti-Infective Agents; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Lung; Mice; Microbial Sensitivity Tests; Naphthyridines; Phenotype; Pneumonia, Pneumococcal; Quinolines; Streptococcus pneumoniae; Survival Analysis | 2004 |
Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Hospitalization; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2007 |